| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 06/30/2011 | US20110160181 Substituted pyrazoline compounds, their preparation and use as medicaments |
| 06/30/2011 | US20110160164 Compounds for nonsense suppression and methods for their use |
| 06/30/2011 | US20110160163 INHIBITORS OF p38 |
| 06/30/2011 | US20110160133 Method for inhibiting inflammation and pre-inflammatory cytokine/chemokine expression using a ghrelin analogue |
| 06/30/2011 | US20110160119 Anti-inflammatory compounds and uses thereof |
| 06/30/2011 | US20110159104 Microemulsion |
| 06/30/2011 | US20110159081 Vaccine |
| 06/30/2011 | US20110159047 Stable powder formulations of alum-adsorbed vaccines |
| 06/30/2011 | US20110159041 Chlamydia Trachomatis Genomic Sequence and Polypeptides, Fragments Thereof and Uses Thereof, in Particular for the Diagnosis, Prevention and Treatment of Infection |
| 06/30/2011 | US20110159040 Novel immunogens and methods for discovery and screening thereof |
| 06/30/2011 | US20110159039 Eliciting hcv-specific antibodies |
| 06/30/2011 | US20110159038 Drying process |
| 06/30/2011 | US20110159037 Methods of treating and protecting against human immunodeficiency virus |
| 06/30/2011 | US20110159035 S/o type transdermal immunizing agent |
| 06/30/2011 | US20110159034 Methods and reagents for vaccination which generate a cd8 t cell immune response |
| 06/30/2011 | US20110159033 West nile virus vaccine |
| 06/30/2011 | US20110159032 Modified vaccinia virus ankara for the vaccination of neonates |
| 06/30/2011 | US20110159031 Vaccine to Influenza A Virus |
| 06/30/2011 | US20110159030 Mucosal combination vaccines for bacterial meningitis |
| 06/30/2011 | US20110159029 Measuring degree of polymerisation for meningococcal capsular saccharides that contain sialic acid |
| 06/30/2011 | US20110159028 Compositions and methods for diagnosing and treating urinary tract infections |
| 06/30/2011 | US20110159026 Compositions and methods of enhancing immune responses to flagellated bacterium |
| 06/30/2011 | US20110159025 Methods, agents and peptides for inducing an innate immune response in HIV vaccination |
| 06/30/2011 | US20110159024 Subunits of the adenovirus fiber protein and uses thereof as vaccines |
| 06/30/2011 | US20110159023 Pd-1 antagonists and methods for treating infectious disease |
| 06/30/2011 | US20110159022 Immunogenic Peptides Derived from the Midkine Protein, as an Anticancer Vaccine |
| 06/30/2011 | US20110159020 Transcription Factor for Killer Cell Activation, Differentiation and Uses Thereof |
| 06/30/2011 | US20110159019 2,4-diaminopyrimidine compound |
| 06/30/2011 | US20110159007 Stable and soluble antibodies inhibiting tnf alpha |
| 06/30/2011 | US20110159003 Ligands That Bind Il-4 and/or Il-13 |
| 06/30/2011 | US20110159002 Stabilized liquid egg material for extended shelf life |
| 06/30/2011 | US20110159000 Antibodies with mannose binding lectin effector function for inhibiting pathologic inflammatory conditions |
| 06/30/2011 | US20110158998 Helminth antigen and immunotherapy |
| 06/30/2011 | US20110158997 Single chain fragment variable antibody libraries and uses thereof |
| 06/30/2011 | US20110158995 Multi-Specific Binding Proteins Targeting B Cell Disorders |
| 06/30/2011 | US20110158993 Train-R: A Cysteine Rich Member of the TNF-Receptor Family |
| 06/30/2011 | US20110158992 Engineered Anti-IL-23R Antibodies |
| 06/30/2011 | US20110158981 Methods and Compositions for Inhibiting Binding of IgE to a High Affinity Receptor |
| 06/30/2011 | US20110158977 Immunogenic compositions for Chlamydia trachomatis |
| 06/30/2011 | US20110158968 Methods of making enhanced, autologous fat grafts |
| 06/30/2011 | US20110158959 Immunophenotype and immunogenicity of human adipose derived cells |
| 06/30/2011 | US20110158957 Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases |
| 06/30/2011 | US20110158955 Method for producing cells having characteristic of hematopoietic stem cells/progenitor cells |
| 06/30/2011 | US20110158943 Interferon alpha 2b modified by polyethylene glycol, the preparation and use thereof |
| 06/30/2011 | US20110158941 Crystalline recombinant interferon with altered spatial configuration, three-dimensional structure and uses thereof |
| 06/30/2011 | US20110158940 Samll molecule inhibitors for the treatment or prevention of dengue virus infection |
| 06/30/2011 | US20110158938 Il-15 binding site for il 15-ralpha and specific il-15 mutants having agonists / antagonists activity |
| 06/30/2011 | US20110158937 Synergistic stimulation of the immune system using immunostimulatory oligonucleotides and/or immunomer compounds in conjunction with cytokines and/or chemotherapeutic agents or radiation therapy |
| 06/30/2011 | US20110158910 Microparticles comprising polymers with thioester bonds |
| 06/30/2011 | US20110158905 Dock-and-Lock (DNL) Complexes for Therapeutic and Diagnostic Use |
| 06/30/2011 | CA2786950A1 Fused heteroaromatic pyrrolidinones as syk inhibitors |
| 06/30/2011 | CA2785353A1 Aminoalkylpyrimidine derivatives as histamine h4 receptor antagonists |
| 06/30/2011 | CA2784447A1 Immunogenic compositions and related methods |
| 06/30/2011 | CA2784180A1 Seven-membered ring compound and pharmaceutical use therefor |
| 06/30/2011 | CA2784179A1 Emulsion composition |
| 06/30/2011 | CA2783955A1 Immunogenic compositions |
| 06/29/2011 | EP2339013A1 Methods for producing modified glycoproteins |
| 06/29/2011 | EP2338908A1 Peptides containing post-translational modifications and their use in the treatment of autoimmune pathologies |
| 06/29/2011 | EP2338900A1 A method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby |
| 06/29/2011 | EP2338517A1 Method for treatment or prevention of disease associated with functional disorder of regulatory T cell |
| 06/29/2011 | EP2338516A2 Multiple-variable dose regimen for treating TNF-alpha-related disorders |
| 06/29/2011 | EP2338515A2 Antibodies that bind human interleukin-18 and methods of making and using |
| 06/29/2011 | EP2338499A1 5' triphosphate oligonucleotide induces anti-viral response |
| 06/29/2011 | EP2338497A1 Treatment and prevention of heat shock protein-associated diseases and conditions |
| 06/29/2011 | EP2337779A2 2-oxo-1,2-dihydro-quinoline modulators of immune function |
| 06/29/2011 | EP2337573A1 Whey and thymus function |
| 06/29/2011 | EP2337569A2 Compositions and methods for characterizing and restoring gastrointestinal, skin, and nasal microbiota |
| 06/29/2011 | EP2217253B1 Bifidobacterium for dust mite allergy |
| 06/29/2011 | EP1658097B1 Nucleotide and cellular vaccine composition |
| 06/29/2011 | EP1576014B1 Antibodies against pd-1 and uses thereof |
| 06/29/2011 | EP1379225B1 Novel medicament compositions based on anticholinergic agents and endothelin antagonists |
| 06/29/2011 | EP1322315B1 Formulations for reducing or eliminating toxicity of environmental hormones containing ursodeoxycholic acid |
| 06/29/2011 | EP1233943B1 Ionizable indolinone derivatives and their use as ptk ligands |
| 06/29/2011 | CN1842602B Modified vaccinia virus ankara (MVA) mutant and use thereof |
| 06/29/2011 | CN1427889B Hybrid cells obtainable from antigen presenting cells |
| 06/29/2011 | CN102112495A Dual variable domain immunoglobulins and uses thereof |
| 06/29/2011 | CN102112494A Dual variable domain immunoglobulins and uses thereof |
| 06/29/2011 | CN102112491A Anti-CD8 antibodies block priming of cytotoxic effectors and lead to generation of regulatory CD8+t cells |
| 06/29/2011 | CN102112484A Triterpene saponins, methods of synthesis, and uses thereof |
| 06/29/2011 | CN102112462A Aminopropylidene derivative |
| 06/29/2011 | CN102112453A Novel potassium channel blockers and uses thereof |
| 06/29/2011 | CN102112149A Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of various diseases |
| 06/29/2011 | CN102112146A Immunity inducer |
| 06/29/2011 | CN102112135A Vaccine composition containing synthetic adjuvant |
| 06/29/2011 | CN102108372A Preparation method and application of beta-glucan |
| 06/29/2011 | CN102108350A Preparation method of bromelin |
| 06/29/2011 | CN102108098A Crocodile collagen, and preparation and use thereof |
| 06/29/2011 | CN102107001A Application of LXR nuclear receptor agonist in treatment and prevention of autoimmune diseases |
| 06/29/2011 | CN102106970A Crocodile gall wine as well as preparation method and use thereof |
| 06/29/2011 | CN102106926A Chinese medicinal composition for immunoregulation of chronic hepatitis B in inactive phase or carrier state |
| 06/29/2011 | CN102106914A Medicament for treating infectious diseases, preparation method and application thereof |
| 06/29/2011 | CN102106909A Fuzheng Zengxiao Anti-cancer Chinese herbal medicine and preparation method thereof |
| 06/29/2011 | CN102106886A Method for extracting effective components of echinacea purpurea by utilizing microwave technology |
| 06/29/2011 | CN102106884A Medicinal composition having immunity-regulating function |
| 06/29/2011 | CN102106878A Preparation method of ginkgo leaf extract liquid-filling capsule |
| 06/29/2011 | CN102106873A Crocodile meat extract and preparation method and application thereof |
| 06/29/2011 | CN102106872A Crocodile blood freeze-dried powder, and preparation method and application thereof |
| 06/29/2011 | CN102106863A Water sprinkling anti-stress agent for aquaculture |
| 06/29/2011 | CN102106835A Method for preparing simvastatin tablet by employing micronizing and power direct compressing technologies |
| 06/29/2011 | CN102106828A Thymalfasin sustained-release microsphere preparation and preparation method thereof |